Delivery Order SPE2DE21D7020-SPE2D625F1CAJ
- Not listed
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $18,953.95 for agent drug-coated balloon supplies. The contract, awarded on June 6, 2025, with an ultimate completion date of June 11, 2025, is funded through the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment represents Boston Scientific's continued role as a critical supplier...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $18,134.55 for agent drug-coated balloons by the Defense Health Agency's Medical Supply Chain on August 8, 2025. The delivery order, which carries an ultimate completion date of August 15, 2025, represents a competitive award with no set-aside designation. The contract employs fixed-price pricing with economic price adjustment mechanisms...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $13,356.93 for drug-coated balloons under a fixed-price contract with economic price adjustment provisions. The award was issued on August 11, 2025, with an ultimate completion date of August 18, 2025. The contract was funded by the Defense Health Agency's Medical Supply Chain and represents an open competition award with no set-aside designation. Drug-coated balloons are...
- Boston Scientific Corp has been awarded a delivery order valued at $21,828.61 for Agent Drug Coated Balloon devices under a fixed price contract with economic price adjustment provisions. The contract was awarded on July 22, 2025, by the Defense Health Agency's Medical Supply Chain and is scheduled for completion by July 29, 2025. This delivery order represents Boston Scientific's continued provision of advanced cardiovascular medical devices to federal healthcare agencies. The award is not...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order to Boston Scientific Corp for agent drug-coated balloons with a ceiling value of $6,175. The contract is a fixed-price agreement with economic price adjustment provisions, with an ultimate completion date of August 21, 2025. This delivery order was not set aside for any specific business category and will be performed at Boston Scientific's Marlborough, Massachusetts facility. As a prime contractor, Boston Scientific is...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order to Boston Scientific Corp on August 15, 2025, for agent drug-coated balloons, with a ceiling value of $13,590.30. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 22, 2025, and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. The award carries no set-aside designation, indicating open competition in the federal marketplace. Drug-coated...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $8,714.55 to Boston Scientific Corp for drug-coated balloons, with performance scheduled to conclude by July 25, 2025. This fixed-price delivery order with economic price adjustment represents a competitive contract with no set-aside designation. Boston Scientific, headquartered in Marlborough, Massachusetts, will perform work at its primary facility in the same location. The contract exemplifies the ongoing...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $55,947.15 by the Defense Health Agency's Medical Supply Chain on July 29, 2025, with an ultimate completion date of August 5, 2025. The contract, which carries no set-aside designation, calls for the delivery of Ranger Global DCB (drug-coated balloon) devices measuring 4.0 x 120mm with a 150cm length. Performance will take place at Boston...
- This is a $37,050 fixed-price with economic price adjustment delivery order contract awarded to Boston Scientific Corp by the Defense Logistics Agency (DLA) for the supply of drug-coated balloons, which are a type of medical device used in cardiovascular procedures. The contract has a performance period that extends to May 2024. Boston Scientific, a leading manufacturer of medical technologies, has been providing a wide range of innovative medical devices and services to federal healthcare...
- This is a delivery order under a federal contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corporation, a leading manufacturer of medical devices. The contract, valued at $6,175, is for the delivery of agent drug-coated balloons. The contract has a fixed-price with economic price adjustment pricing type and a completion date of July 11, 2024. Boston Scientific is a for-profit organization and the manufacturer of the goods being delivered. The award is not associated...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F1CAJDelivery Order
Boston Scientific Corp has been awarded a delivery order valued at $6,175.00 for agent drug-coated balloons under the Defense Health Agency's Medical Supply Chain contract vehicle. The award, issued on August 15, 2025, with an ultimate completion date of August 22, 2025, represents a fixed-price contract with economic price adjustment provisions. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, the company's headquarters location. This delivery order was not set aside for any specific business category and represents part of the company's ongoing federal healthcare supply obligations. Boston Scientific Corp, a global medical technology company, serves as a prime contractor across multiple federal healthcare agencies, including the Department of Veterans Affairs and the Defense Health Agency, providing specialized cardiovascular intervention devices and medical equipment. Drug-coated balloons are advanced interventional cardiology devices used in percutaneous coronary intervention procedures to treat coronary artery disease. This delivery order falls within Boston Scientific's broader portfolio of federal contracts valued at hundreds of thousands to millions of dollars, demonstrating the company's critical role in supporting federal healthcare systems' access to innovative medical technologies and maintaining the medical supply chain for defense health operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 8/15/25 |